Clinical trials: Infantile Hemangiomas
Hemangioma
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
Infantile hemangioma (IH) is the most common benign vascular tumor in pediatric population. Oral propranolol is the treatment of choice for complicated hemangiomas.
- Trial name
- NCT02731287
- Testing
- Timolol
- Where
- 2 sites in Spain
- Volunteers
- 70 people
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Infantile Hemangioma (IH)
Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma
To assess and compare the efficacy of systemic beta-blocker therapy with the efficacy and safety of fractional carbon dioxide laser-assisted delivery of a topical beta-blocker solution in the treatment of infantile hemangioma.
- Trial name
- NCT07560332
- Testing
- Propranolol 1, Fractional CO2 laser with topical timolol
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Cairo University
Hemangioma
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
The goal of this study is to determine the safety and efficacy of Prednisolone and Vincristine for treatment of large, complicated infantile hemangiomas.
- Trial name
- NCT00555464
- Testing
- Vincristine, Prednisone
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Medical College of Wisconsin
Adenovirus, Anesthesia
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Understudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug administration will be involved.
- Conditions
- Adenovirus, Anesthesia, Anxiety, Anxiolysis
- Trial name
- PTN_POPS (NCT01431326)
- Testing
- The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
- Where
- 52 sites in United States, Canada and 3 more
- Volunteers
- 3,520 people
- Sponsor
- Daniel Benjamin
Hemangioma, Propranolol
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
Infantile hemangiomas are widespread vascular tumours having incidence of 10% and most of them involute spontaneously. However, they are known to be located in proximity of vital organs and can have poor cosmetic and functional…
- Trial name
- NCT05327309
- Testing
- Bleomycin
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
Infantile Hemangioma
Hemangiol, Post Marketing Surveillance Study
Infantile hemangioma is a benign tumor belonging to the group of vascular tumors in the ISSVA classification (International Society for the Study of Vascular Anomalies). The diagnosis is clinical and radiological.
- Trial name
- postHemangiol (NCT04105517)
- Where
- France
- Volunteers
- 500 people
- Sponsor
- University Hospital, Montpellier
Neck Mass, Thyroglossal Duct Cysts
Computer Aided Tool for Diagnosis of Neck Masses in Children
The aim of this study was to evaluate the diagnostic efficacy of computer aided diagnostic tool for neck masses using machine learning and deep learning techniques on clinical information and radiological images in children.
- Conditions
- Neck Mass, Thyroglossal Duct Cysts, Branchial Cleft Anomalies, Dermoid and Epidermoid Cysts
- Trial name
- NCT05187923
- Testing
- Artificial Intelligence Algorithm
- Where
- China
- Volunteers
- 1,500 people
- Sponsor
- West China Hospital
Hemangioma
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
The purpose of this study is to compare the efficacy of orally administered propranolol versus atenolol in the treatment of potentially disfiguring or functionally threatening IHs.
- Trial name
- NCT02342275
- Testing
- Propranolol, Atenolol
- Where
- China
- Volunteers
- 377 people, healthy volunteers welcome
- Sponsor
- West China Hospital
Hemangioma
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
Infantile Hemangioma (IH) is infancy's most common vascular tumor of infancy and most frequent benign neoplasm. Treatment of IHs is indicated for approximately 10 to 20% of the cases.
- Trial name
- NCT01072045
- Testing
- Propranolol, Prednisone
- Where
- Brazil
- Volunteers
- 50 people
- Sponsor
- University of Sao Paulo
Hemangioma
Clinical Characteristics of Infantile Hemangioma
The primary purpose of this study is to identify the clinical characteristics of infantile hemangioma (IH) in our single center in China.
- Trial name
- NCT03331744
- Where
- China
- Volunteers
- 1,000 people
- Sponsor
- West China Hospital
Hemangioma Skin
Topical Simvastatin for Treating Infantile Hemangioma
This is a 48-week, open-label pilot study to evaluate the safety, including systemic exposure and skin tolerability, and preliminary efficacy of 5% simvastatin ointment in the treatment of 15 children with newly diagnosed…
- Trial name
- TSTIH (NCT06273111)
- Testing
- 5% simvastatin ointment
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Joyce Teng
Infantile Hemangioma
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
The purpose of this study is to assess the safety and efficacy of Timolol 0.25% and 0.5% doses.
- Trial name
- TIM01 (NCT02913612)
- Testing
- 0.25% Timolol Maleate Gel Forming Solution, 0.5% Timolol Maleate Gel Forming Solution
- Where
- 12 sites in United States
- Volunteers
- 105 people
- Sponsor
- Kanecia Obie Zimmerman
Hemangioma
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
There is no effective treatment for hemangioma regardless of immediate severity. That is in this respect a orphan disease. These hemangiomas, sometimes large, will have a phase of proliferation of several months (very scary for…
- Trial name
- NCT01743885
- Testing
- Acebutolol, Propanolol
- Where
- 4 sites in France
- Volunteers
- 55 people
- Sponsor
- University Hospital, Montpellier
Infantile Hemangioma (IH)
Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested Growth
Infantile hemangioma with minimal or arrested growth (IH-MAG) is a subtype of infantile hemangioma that shows little or no obvious growth during infancy.
- Trial name
- IH-MAGRST (NCT07669545)
- Testing
- Routine Clinical Assessment and Risk Stratification
- Where
- China
- Volunteers
- 150 people
- Sponsor
- West China Hospital
Hemangioma, Infant
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas.
- Trial name
- NCT01147601
- Testing
- topical 0.5% Timolol
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Oregon Health and Science University
Hemangioma
Clinical Characteristics of Lip Hemangiomas
Lip hemangiomas are at higher risk than those located in other sites. However, studies about clinical characteristics of lip hemangiomas have not been enough.
- Trial name
- NCT02351245
- Testing
- observation
- Volunteers
- 39 people
- Sponsor
- Zhujiang Hospital
Hemangioma, Capillary
Propranolol in Capillary Hemangiomas
The investigators observed that Propranolol, a beta-blocker commonly used in children was efficient to control the growth of alarming hemangiomas of the face.
- Trial name
- HEMANGIOMA (NCT00744185)
- Testing
- propranolol treatment
- Where
- France
- Volunteers
- 14 people
- Sponsor
- University Hospital, Bordeaux
LUMBAR Syndrome
Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas
The objective of this study is to determine the maximal diameter threshold at which infants with lumbosacral, sacrococcygeal, perineal, gluteal, or lower-limb extending infantile hemangiomas should undergo screening for LUMBAR…
- Trial name
- NCT07616323
- Testing
- MRI
- Where
- China
- Volunteers
- 70 people
- Sponsor
- West China Hospital